Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of directors of Amalgamated entity i.e Dishman Carbogen Amcis Limited, in its meeting held on May 19, 2017 has fixed Record Date as May 31, 2017 for the purpose of deciding the members who shall be eligible for allotment of equity shares of the amalgamated entity, Dishman Carbogen Amcis Limited to the shareholders of erstwhile Dishman Pharmaceuticals and Chemicals Limited ("DPCL") in the ratio of 1:1 i.e. Share Exchange Ratio [1 (One) fully paid-up Equity Share of Rs.2/- (Rupees Two only) each of DCAL, for every 1 (One) fully paid-up Equity Share of Rs.2/ (Rupees Two only) each held by such shareholder in DPCL], fixed under the Scheme of Arrangement and Amalgamation approved by the Hon'ble High Court of Gujarat.

Dishman Pharmaceuticals & Chemicals Ltd. is pharmaceutical company whose business is organized under the following segments: QUATs and specialty chemicals, intermediates and APIs, contract manufacturing and contract research.

Dishman Pharmaceuticals & Chemicals Ltd (DISH IN)

Record Date

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Investor Presentation

Investor Presentation

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.

Financial Result Updates

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00